Alessandra Bandera Selected Research

Dysbiosis

1/2023	Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID.
8/2020	Multidrug-Resistant Gram-Negative Bacteria Decolonization in Immunocompromised Patients: A Focus on Fecal Microbiota Transplantation.
1/2018	Altered gut microbiome composition in HIV infection: causes, effects and potential intervention.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandra Bandera Research Topics

Disease

48	COVID-19 05/2024 - 01/2020
43	Infections 05/2024 - 09/2005
19	HIV Infections (HIV Infection) 01/2024 - 08/2004
9	Inflammation (Inflammations) 01/2023 - 08/2015
8	Neoplasms (Cancer) 01/2024 - 03/2013
7	Pneumonia (Pneumonitis) 01/2023 - 08/2019
5	Sepsis (Septicemia) 01/2024 - 10/2018
4	Acute Kidney Injury (Acute Renal Failure) 04/2023 - 10/2018
4	Respiratory Insufficiency (Respiratory Failure) 11/2022 - 10/2020
4	Viremia 02/2021 - 08/2010
3	Acquired Immunodeficiency Syndrome (AIDS) 04/2024 - 08/2015
3	Breakthrough Infections 01/2024 - 01/2023
3	Dysbiosis 01/2023 - 01/2018
3	Disease Progression 01/2023 - 01/2019
3	Septic Shock (Toxic Shock Syndrome) 05/2022 - 01/2021
3	Coinfection 11/2021 - 01/2020
2	Lung Diseases (Lung Disease) 12/2023 - 09/2023
2	Persistent Infection 11/2023 - 11/2021
2	Cross Infection (Nosocomial Infection) 03/2023 - 12/2019
2	Fibrosis (Cirrhosis) 01/2023 - 12/2019
2	Critical Illness (Critically Ill) 01/2022 - 12/2021
2	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2022 - 01/2022
2	Arthritis (Polyarthritis) 01/2022 - 01/2022
2	Ventilator-Associated Pneumonia 01/2022 - 01/2021
2	Reinfection 01/2022 - 01/2021
2	Hypersensitivity (Allergy) 12/2021 - 09/2021
2	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 01/2019
1	Hemorrhage 05/2024
1	Communicable Diseases (Infectious Diseases) 03/2024
1	Patent Ductus Arteriosus 01/2024
1	Adenocarcinoma of Lung 09/2023

Drug/Important Bio-Agent (IBA)

14	VaccinesIBA 01/2024 - 01/2021
10	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2015
10	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2012
10	AntibodiesIBA 02/2022 - 01/2020
7	BNT162 VaccineIBA 01/2024 - 01/2021
5	Oxygen (Dioxygen)IBA 03/2024 - 01/2021
5	Immune Checkpoint InhibitorsIBA 09/2023 - 01/2021
5	Proteins (Proteins, Gene)FDA Link 02/2023 - 01/2021
5	Immunoglobulin G (IgG)IBA 01/2023 - 01/2021
4	Messenger RNA (mRNA)IBA 01/2023 - 01/2021
4	COVID-19 VaccinesIBA 01/2023 - 09/2021
3	Carbapenems (Carbapenem Antibiotics)IBA 03/2024 - 03/2023
3	Neutralizing AntibodiesIBA 01/2024 - 01/2021
3	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 01/2021
3	Monoclonal AntibodiesIBA 05/2023 - 08/2022
3	CytokinesIBA 01/2023 - 09/2005
3	2019-nCoV Vaccine mRNA-1273IBA 01/2023 - 01/2021
3	Antirheumatic Agents (DMARD)IBA 01/2022 - 01/2022
3	Antiviral Agents (Antivirals)IBA 12/2021 - 03/2014
3	C-Reactive ProteinIBA 10/2021 - 01/2021
3	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2021 - 07/2020
3	ABO Blood-Group SystemIBA 01/2021 - 10/2020
2	Heparin (Liquaemin)FDA LinkGeneric 05/2024 - 01/2022
2	InterferonsIBA 03/2024 - 09/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 01/2021
2	Darunavir (Prezista)FDA Link 01/2024 - 01/2018
2	carbapenemaseIBA 04/2023 - 01/2021
2	ProteomeIBA 02/2023 - 01/2021
2	RacivirIBA 01/2023 - 01/2018
2	mRNA VaccinesIBA 01/2023 - 01/2021
2	proadrenomedullinIBA 05/2022 - 01/2022
2	MicroRNAs (MicroRNA)IBA 03/2022 - 11/2014
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 08/2019
2	Platelet Factor 4IBA 01/2022 - 01/2022
2	Immunomodulating AgentsIBA 01/2022 - 01/2017
2	Immunoglobulin A (IgA)IBA 01/2022 - 11/2021
2	fibrin fragment D (D-dimer)IBA 01/2022 - 01/2021
2	Immunoglobulin M (IgM)IBA 01/2022 - 11/2021
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 02/2021 - 07/2020
2	Ferritins (Ferritin)IBA 02/2021 - 01/2021
2	Complement System Proteins (Complement)IBA 01/2021 - 01/2021
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2018 - 12/2010
2	HDL CholesterolIBA 09/2016 - 01/2016
2	tucaresolIBA 09/2005 - 08/2004
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 05/2024
1	Third Generation CephalosporinsIBA 03/2024
1	Ampicillin (Omnipen)FDA LinkGeneric 01/2024
1	AminoglycosidesIBA 01/2024
1	Cefotaxime (Kendrick)FDA LinkGeneric 01/2024
1	Zidovudine (Retrovir)FDA LinkGeneric 01/2024
1	Cadherins (E-Cadherin)IBA 11/2023
1	Air Pollutants (Pollutants, Air)IBA 11/2023
1	Environmental Pollutants (Pollutants, Environmental)IBA 11/2023
1	insulin receptor-related receptor (IRR)IBA 11/2023

Therapy/Procedure

18	Therapeutics 05/2024 - 11/2010
7	Liver Transplantation 01/2024 - 01/2019
6	Art Therapy 01/2023 - 08/2010
4	Critical Care (Surgical Intensive Care) 03/2024 - 01/2021
4	Artificial Respiration (Mechanical Ventilation) 04/2023 - 01/2021
4	Highly Active Antiretroviral Therapy (HAART) 10/2019 - 01/2009
3	Transplantation 01/2023 - 01/2020
3	Stem Cell Transplantation 05/2022 - 06/2006
2	Length of Stay 05/2022 - 12/2019
2	Immunomodulation 01/2022 - 08/2004
1	Noninvasive Ventilation 04/2024
1	Continuous Positive Airway Pressure 04/2024
1	Time-to-Treatment 04/2024
1	Analgesia 03/2024
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2024